Clinical Trial Update: Health-Related Outcomes in Patients Who Were Previously Treated for Rhabdomyosarcoma [NA]

View source ↗

Summary

This Clinical Trial Update reports health-related outcomes in patients who were previously treated for rhabdomyosarcoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rhabdomyosarcoma
• Sarcoma

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Long-term Effects Secondary to Cancer Therapy in Children, Sarcoma | NA | Status: COMPLETED